Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland

Abstract Background The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in the rapid ∼15% increase in the number of followed-up people with h...

Full description

Saved in:
Bibliographic Details
Published in:Clinical infectious diseases 2023-05, Vol.76 (10), p.1708-1715
Main Authors: Parczewski, Miłosz, Jabłonowska, Elżbieta, Wójcik-Cichy, Kamila, Zhyvytsia, Dmytro, Witak-Jędra, Magdalena, Leszczyszyn-Pynka, Magdalena, Aksak-Wąs, Bogusz, Siwak, Ewa, Cielniak, Iwona, Olczak, Anita, Szymczak, Aleksandra, Szetela, Bartosz, Bociąga-Jasik, Monika, Kalinowska-Nowak, Anna, Mularska, Elżbieta, Witor, Adam, Jakubowski, Paweł, Hlebowicz, Maria, Rozpłochowski, Błażej, Łojewski, Władysław, Scheibe, Kaja, Serwin, Karol
Format: Article
Language:English
Subjects:
Anti-HIV Agents - therapeutic use
Anti-Retroviral Agents - therapeutic use
Drug Resistance, Viral - genetics
Female
HIV Infections - drug therapy
HIV Infections - epidemiology
HIV-1 - genetics
Humans
Male
Poland - epidemiology
Refugees
RNA-Directed DNA Polymerase - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in the rapid ∼15% increase in the number of followed-up people with human immunodeficiency virus (HIV) (PWH) in the country. Here, we present the national experience on HIV care provided for refugees from Ukraine. Methods Clinical, antiretroviral, immunological, and virologic data from 955 Ukrainian PWH entering care in Poland since February 2022 were analyzed. The dataset included both antiretroviral-treated (n = 851) and newly diagnosed (n = 104) patients. In 76 cases, protease/reverse transcriptase/integrase sequencing was performed to identify drug resistance and subtype. Results Most (70.05%) of the patients were female, with a predominance of heterosexual (70.3%) transmissions. Anti–hepatitis C antibody and hepatitis B antigen were present in 28.7% and 2.9% of the patients, respectively. A history of tuberculosis was reported in 10.1% of cases. Among previously treated patients, the viral suppression rate was 89.6%; 77.3% of newly HIV diagnosed cases were diagnosed late (with lymphocyte CD4 count
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciad116